95 | Temozolomide (Temodar)FDA LinkGeneric
03/2024
-
03/2002 |
72 | Proteins (Proteins, Gene)FDA Link
12/2023
-
01/2002 |
52 | Biomarkers (Surrogate Marker)IBA
05/2024
-
12/2007 |
50 | Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA
05/2024
-
10/2009 |
40 | Bevacizumab (Avastin)FDA Link
01/2024
-
04/2010 |
39 | DNA (Deoxyribonucleic Acid)IBA
05/2024
-
02/2006 |
33 | Messenger RNA (mRNA)IBA
11/2022
-
05/2002 |
30 | LigandsIBA
07/2022
-
01/2002 |
29 | Alkylating AgentsIBA
05/2024
-
03/2005 |
27 | MethyltransferasesIBA
05/2024
-
02/2006 |
26 | Lomustine (CCNU)FDA Link
01/2024
-
05/2002 |
26 | CytokinesIBA
01/2023
-
10/2003 |
21 | ErbB Receptors (EGF Receptor)IBA
10/2021
-
01/2002 |
20 | Transforming Growth Factors (Transforming Growth Factor)IBA
01/2022
-
10/2004 |
20 | Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
06/2021
-
08/2002 |
19 | AntigensIBA
11/2023
-
05/2003 |
17 | Transforming Growth Factor beta (TGF-beta)IBA
12/2016
-
10/2004 |
16 | IntegrinsIBA
01/2024
-
12/2009 |
16 | Immune Checkpoint InhibitorsIBA
01/2024
-
08/2015 |
15 | CilengitideIBA
01/2024
-
12/2009 |
14 | CaspasesIBA
04/2020
-
03/2002 |
13 | O-(6)-methylguanineIBA
01/2024
-
02/2006 |
12 | Phosphotransferases (Kinase)IBA
01/2023
-
11/2004 |
12 | Vincristine (Oncovin)FDA LinkGeneric
07/2020
-
09/2002 |
12 | O(6)-Methylguanine-DNA MethyltransferaseIBA
07/2014
-
09/2008 |
11 | SteroidsIBA
04/2024
-
12/2010 |
11 | Anticonvulsants (Antiepileptic Drugs)IBA
01/2023
-
08/2005 |
11 | Procarbazine (Matulane)FDA Link
07/2020
-
10/2002 |
10 | AntibodiesIBA
03/2019
-
01/2002 |
9 | Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2023
-
05/2002 |
9 | Peptides (Polypeptides)IBA
01/2023
-
08/2002 |
9 | Death Domain ReceptorsIBA
09/2013
-
01/2002 |
8 | Angiogenesis InhibitorsIBA
11/2023
-
09/2010 |
8 | Fas Ligand Protein (Fas Ligand)IBA
11/2022
-
01/2002 |
8 | Adrenal Cortex Hormones (Corticosteroids)IBA
03/2021
-
12/2010 |
8 | MicroRNAs (MicroRNA)IBA
01/2020
-
08/2011 |
8 | EnzymesIBA
01/2016
-
05/2005 |
7 | VaccinesIBA
01/2023
-
01/2004 |
7 | Monoclonal AntibodiesIBA
01/2023
-
10/2013 |
7 | epidermal growth factor receptor VIIIIBA
12/2022
-
12/2012 |
7 | InterferonsIBA
01/2022
-
09/2012 |
7 | Neutralizing AntibodiesIBA
12/2019
-
11/2003 |
6 | Amino AcidsFDA Link
01/2024
-
01/2003 |
6 | RNA (Ribonucleic Acid)IBA
01/2022
-
10/2006 |
6 | Small Interfering RNA (siRNA)IBA
10/2017
-
10/2004 |
6 | Methotrexate (Mexate)FDA LinkGeneric
09/2017
-
02/2002 |
6 | HLA-G Antigens (HLA G)IBA
11/2005
-
05/2002 |
5 | 14- methyl- 20- oxa- 5,7,14,26- tetraazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa- 1(25),2(26),3,5,8(27),9,11,16,21,23- decaeneIBA
04/2024
-
01/2019 |
5 | Cyclin-Dependent Kinases (cdk Proteins)IBA
12/2023
-
12/2009 |
5 | depatuxizumab mafodotinIBA
01/2023
-
01/2020 |
5 | Fibronectins (Fibronectin)IBA
03/2022
-
01/2013 |
5 | Telomerase (Telomerase Reverse Transcriptase)IBA
01/2021
-
12/2013 |
5 | Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
11/2020
-
01/2016 |
5 | Protein Isoforms (Isoforms)IBA
01/2018
-
11/2013 |
5 | AcidsIBA
06/2016
-
01/2005 |
5 | Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2016
-
05/2013 |
5 | CeramidesIBA
01/2013
-
09/2007 |
4 | Histones (Histone)IBA
05/2024
-
08/2013 |
4 | Proteasome Endopeptidase Complex (Proteasome)IBA
03/2024
-
08/2007 |
4 | Glutamic Acid (Glutamate)FDA Link
01/2024
-
07/2018 |
4 | Chimeric Antigen ReceptorsIBA
11/2023
-
01/2018 |
4 | Interferon Type IIBA
02/2023
-
12/2017 |
4 | NivolumabIBA
01/2023
-
01/2017 |
4 | ChromatinIBA
01/2023
-
05/2005 |
4 | Levetiracetam (Keppra)FDA LinkGeneric
01/2022
-
02/2012 |